Mode
Text Size
Log in / Sign up

RA PRO dashboard shows no significant short-term effects on patient decision-making or medication adherenceNew Dashboard Shows Limited Impact on Rheumatoid Arthritis Care

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that the RA PRO dashboard did not significantly improve medication adherence or decision-making in the short term.

This stepped-wedge cluster randomized pragmatic trial involved 23 clinicians and 554 patients with rheumatoid arthritis at a single academic rheumatology clinic. The study evaluated the RA PRO dashboard, an electronic health record sidecar application designed to visualize disease activity, physical function, and pain through a patient-facing graphical interface.

The primary outcomes included the 4-item SURE scale of decisional conflict, PROMIS-SE 4a, Beliefs about Medicines Questionnaire-Specific Necessity-Concerns, and medication adherence. Analysis of these metrics across 1,083 study visits revealed limited effects of the intervention. Specifically, no significant short-term effects were observed for patient decision-making, self-efficacy in symptom management, or medication beliefs.

Safety data regarding adverse events or discontinuations were not reported. A notable limitation was that clinician adoption of the dashboard was highly variable. While qualitative data indicated positive perceptions of the care experience, these did not translate into improvements in measured behavioral outcomes. The study suggests the dashboard's impact on traditional behavioral outcomes is limited in the short term.

How this fits prior evidence

How this fits prior evidence: This finding addresses a gap regarding digital health interventions for rheumatoid arthritis. While previous coverage established that JAK inhibitors show 81.7% treatment retention and specific measures like MDA and ACR20 best discriminate treatment response, this study focuses on the role of patient-facing dashboards in improving behavioral outcomes. The results indicate that such tools do not currently provide significant short-term improvements in medication adherence or decision-making for RA patients.

Researchers studied a new electronic health record tool called the RA PRO dashboard. This tool was designed to help patients with rheumatoid arthritis see their disease activity, physical function, and pain through a visual interface. The goal was to see if this visual data would help patients manage their symptoms better.

The study included 554 patients and 23 clinicians at an academic rheumatology clinic. While the dashboard received positive feedback from some users regarding the overall care experience, the actual results showed limited impact. Specifically, there were no significant short-term changes in how patients made decisions or their confidence in managing symptoms.

Because of these findings, it is important to note that while the tool was well received by some, it did not change core behaviors like medication adherence. The study also noted that clinicians used the dashboard at very different rates. These results suggest that this specific digital tool may not be a primary solution for improving patient behavior in the short term.

What this means for you:
A new visual dashboard showed no significant improvement in decision making or medication adherence for RA patients.

Common questions

What was the RA PRO dashboard designed to do?

The RA PRO dashboard was an electronic health record application. It was designed to provide a visual interface for patients with rheumatoid arthritis. This tool aimed to help patients see their disease activity, physical function, and pain levels more clearly during their care.

Did the dashboard improve how patients managed their medication?

The study found limited effects on several outcomes, including medication adherence and patient decision making. There were no significant short-term changes in these areas for the 554 patients involved in the trial.

Why did the results show limited improvement?

While some qualitative data showed that patients liked the experience of using the dashboard, these positive feelings did not translate into measurable changes in behavior. Additionally, the study noted that clinician use of the tool varied greatly.

Study Details

Study typeRct
Sample sizen = 554
EvidenceLevel 2
PublishedAug 2026
View Original Abstract ↓
OBJECTIVE: We developed a novel electronic health record sidecar application to visualize key rheumatoid arthritis (RA) outcomes, including disease activity, physical function, and pain, via a patient-facing graphical interface designed for use during outpatient visits ("RA PRO dashboard"). Initial qualitative studies showed positive perceptions from patients; here we assessed the effect of the RA PRO dashboard on patient decision-making, self-efficacy in symptom management, medication beliefs, and medication adherence in a randomized pragmatic trial. METHODS: We conducted an open cohort, stepped-wedge cluster-randomized trial at a single academic rheumatology clinic between February 2020 and August 2023. Rheumatology clinicians were randomized as clinician-patient clusters into four intervention sequences (5 time periods). Primary outcome measures derived from patient questionnaires were the 4-item SURE (Sure of myself, Understand information, Risk-benefit ratio, Encouragement) scale of decisional conflict; PROMIS-SE 4a (Patient-Reported Outcomes Measurement Information System-Self-Efficacy for Managing Symptoms); Beliefs about Medicines Questionnaire-Specific Necessity-Concerns differential; and medication adherence. Generalized estimating equations models were used to evaluate the effect of clinician access to the dashboard on each outcome. RESULTS: A total of 23 clinicians were included in the analysis, and 554 patients completed 1,083 study visits, of which 664 were in the intervention group. Adoption of the RA PRO dashboard by clinicians was highly variable. We observed limited effects of the intervention on the outcomes. CONCLUSION: This trial revealed no significant short-term effects of the RA PRO dashboard on measures of patient decision-making, self-efficacy, medication beliefs, or adherence. Despite previous qualitative work showing improvements in the care experience, this study suggests that the dashboard's impact on traditional behavioral outcomes, at least in the short term, is limited.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.